340 related articles for article (PubMed ID: 29301470)
21. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
Mak A; Cheung BM; Mok CC; Leung R; Lau CS
Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
[TBL] [Abstract][Full Text] [Related]
22. Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.
Mak A; Mok CC; Chu WP; To CH; Wong SN; Au TC
Lupus; 2007; 16(1):28-34. PubMed ID: 17283582
[TBL] [Abstract][Full Text] [Related]
23. The clinical relevance of repeat renal biopsies in the management of lupus nephritis: a South African experience.
Tannor EK; Bates WD; Moosa MR
Lupus; 2018 Apr; 27(4):525-535. PubMed ID: 28820361
[TBL] [Abstract][Full Text] [Related]
24. Complication rate and diagnostic yield of percutaneous native kidney biopsies: A 10-year experience at a Tertiary Care Hospital in Pakistan.
Yaqub S; Ahmed N; Fatima U; Maqbool A; Ashif W; Hussain SA
Saudi J Kidney Dis Transpl; 2017; 28(4):891-897. PubMed ID: 28748893
[TBL] [Abstract][Full Text] [Related]
25. Ultrasonography as a predictor of overt bleeding after renal biopsy.
Ishikawa E; Nomura S; Hamaguchi T; Obe T; Inoue-Kiyohara M; Oosugi K; Katayama K; Ito M
Clin Exp Nephrol; 2009 Aug; 13(4):325-331. PubMed ID: 19381759
[TBL] [Abstract][Full Text] [Related]
26. Lupus nephritis in the Western Cape, a high prevalence area: an experience over three decades.
Brijlal U; Bates WD; Moosa MR
Lupus; 2017 Oct; 26(11):1228-1234. PubMed ID: 28420052
[TBL] [Abstract][Full Text] [Related]
27. Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics.
Nielly H; Mathian A; Cazenave M; Izzedine H; Haroche J; Cohen-Aubart F; Hie M; Miyara M; Pineton de Chambrun M; Benameur N; Hausfater P; Pha M; Boutin-Lê Thi Huong D; Rouvier P; Brocheriou I; Cluzel P; Amoura Z
Nephrol Dial Transplant; 2020 Oct; 35(10):1721-1729. PubMed ID: 31157889
[TBL] [Abstract][Full Text] [Related]
28. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages.
Hill GS; Delahousse M; Nochy D; Rémy P; Mignon F; Méry JP; Bariéty J
Kidney Int; 2001 Jan; 59(1):304-16. PubMed ID: 11135084
[TBL] [Abstract][Full Text] [Related]
29. Renal arteriovenous fistula following kidney biopsy in systemic lupus erythematosus.
Leong KH; Boey ML; Feng PH
Singapore Med J; 1993 Aug; 34(4):327-8. PubMed ID: 8266205
[TBL] [Abstract][Full Text] [Related]
30. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
[TBL] [Abstract][Full Text] [Related]
31. Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus.
Chew C; Pemberton PW; Husain AA; Haque S; Bruce IN
Clin Exp Rheumatol; 2013; 31(2):251-5. PubMed ID: 23306163
[TBL] [Abstract][Full Text] [Related]
32. Predictors of kidney disease in a cohort of pediatric patients with lupus.
Sule SD; Moodalbail DG; Burnham J; Fivush B; Furth SL
Lupus; 2015 Jul; 24(8):862-8. PubMed ID: 25680740
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus patients: a retrospective analysis of 3140 cases in a Chinese population.
Mao YM; Shi PL; Wu L; Hu YQ; He YS; Xiang K; Tao JH; Pan HF; Wu GC
Lupus; 2020 Jun; 29(7):743-750. PubMed ID: 32356674
[TBL] [Abstract][Full Text] [Related]
34. Anti-Sm is associated with the early poor outcome of lupus nephritis.
Ahn SS; Yoo BW; Song JJ; Park YB; Lee SK; Lee SW
Int J Rheum Dis; 2016 Sep; 19(9):897-902. PubMed ID: 27126359
[TBL] [Abstract][Full Text] [Related]
35. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
36. Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.
Hara A; Furuichi K; Yamahana J; Yasuda H; Iwata Y; Sakai N; Shimizu M; Kaneko S; Wada T
J Rheumatol; 2016 Jul; 43(7):1328-34. PubMed ID: 27134248
[TBL] [Abstract][Full Text] [Related]
37. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
38. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients.
Vlachoyiannopoulos PG; Karassa FB; Karakostas KX; Drosos AA; Moutsopoulos HM
Lupus; 1993 Oct; 2(5):303-12. PubMed ID: 8305923
[TBL] [Abstract][Full Text] [Related]
39. Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis.
Shahin AA; Mostafa H; Sami H; Shahin HA
Z Rheumatol; 2003 Jun; 62(3):246-50. PubMed ID: 12827401
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of neutrophil gelatinase-associated lipocalin and other laboratory markers for lupus nephritis: a cross-sectional investigation.
La'ulu SL; Suh-Lailam BB; Davis KW; Straseski JA; Tebo AE
Ann Clin Biochem; 2017 Mar; 54(2):240-245. PubMed ID: 27166308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
